{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:12:43Z","timestamp":1771074763858,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["IRAS\u201023727"],"award-info":[{"award-number":["IRAS\u201023727"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Limited","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To determine the feasibility of a definitive study of intravitreal ranibizumab to promote the clearance of persistent diabetic vitreous haemorrhage and thereby avoid vitrectomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This randomised, double\u2010masked, placebo\u2010controlled feasibility study recruited\u00a024 participants with persistent diabetic vitreous haemorrhage listed for pars plana vitrectomy.\u00a0Participants were randomised to a single 0.5\u2010mg intravitreal ranibizumab injection or a single subconjunctival saline injection.\u00a0The primary outcome measure was the\u00a0number of participants requiring pars plana vitrectomy at week 7.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight of 12 participants (66.7%) in the ranibizumab group required vitrectomy at week 7 versus 12 of 12 (100%) in the placebo group (absolute risk reduction 33.3%, 95% confidence interval 2.1\u201370.7%;\u00a0p\u00a0=<jats:italic>\u00a0<\/jats:italic>0.09). One additional eye in the ranibizumab group required vitrectomy by 12\u00a0months. Mean visual acuity letter score at 12\u00a0months was 72.7\u00a0\u00b1\u00a012.3 in the ranibizumab group and 75.1\u00a0\u00b1\u00a010.1 in the placebo group. Safety was similar across groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Intravitreal ranibizumab may reduce the likelihood of proceeding to vitrectomy in patients with persistent, dense diabetic vitreous haemorrhage. Further studies appear feasible and justified.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aos.14282","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T07:20:41Z","timestamp":1572592841000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double\u2010masked, placebo\u2010controlled feasibility study."],"prefix":"10.1111","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-3423","authenticated-orcid":false,"given":"Robert","family":"Petrarca","sequence":"first","affiliation":[{"name":"School of Life Science and Medicine King's College London London UK"},{"name":"Department of Ophthalmology King's College Hospital London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4533-0105","authenticated-orcid":false,"given":"Cristina","family":"Soare","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology King's College Hospital London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology St. Thomas\u2019 Hospital London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riti","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology King's College Hospital London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Neffendorf","sequence":"additional","affiliation":[{"name":"School of Life Science and Medicine King's College London London UK"},{"name":"Department of Ophthalmology King's College Hospital London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Simpson","sequence":"additional","affiliation":[{"name":"School of Life Science and Medicine King's College London London UK"},{"name":"Department of Ophthalmology King's College Hospital London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7618-1555","authenticated-orcid":false,"given":"Timothy L.","family":"Jackson","sequence":"additional","affiliation":[{"name":"School of Life Science and Medicine King's College London London UK"},{"name":"Department of Ophthalmology King's College Hospital London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702980"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001673"},{"key":"e_1_2_6_4_1","first-page":"515","article-title":"Strategies for measuring the rate of age\u2010related cataract formation in vivo","volume":"6","author":"Chylack LT","year":"1989","journal-title":"Lens Eye Toxic Res"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.2015"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(85)34002-2"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050110038020"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070090060040"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.035"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-009-1182-7"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S68661"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(82)90197-0"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181b094b7"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.4587"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.01107.x"},{"key":"e_1_2_6_16_1","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis)","volume":"107","author":"Kaiser PK","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09286580701396720"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.01042.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.031"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.12.039"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.01.010"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.041"},{"key":"e_1_2_6_23_1","first-page":"CD008214","article-title":"Anti\u2010vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","volume":"8","author":"Smith JM","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200603000-00004"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90062-3"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.11.012"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1909"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.100542"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14282","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aos.14282","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T21:58:52Z","timestamp":1693864732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.14282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1111\/aos.14282"],"URL":"https:\/\/doi.org\/10.1111\/aos.14282","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"2019-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}